Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vycor Medical (VYCO) Equity Ratio (2016 - 2025)

Vycor Medical has reported Equity Ratio over the past 16 years, most recently at 4.92 for Q4 2025.

  • Quarterly Equity Ratio fell 33.12% to 4.92 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.92 through Dec 2025, down 33.12% year-over-year, with the annual reading at 4.92 for FY2025, 33.12% down from the prior year.
  • Equity Ratio was 4.92 for Q4 2025 at Vycor Medical, down from 4.28 in the prior quarter.
  • Over five years, Equity Ratio peaked at 2.56 in Q4 2021 and troughed at 4.92 in Q4 2025.
  • The 5-year median for Equity Ratio is 3.39 (2022), against an average of 3.07.
  • Year-over-year, Equity Ratio surged 227.5% in 2021 and then crashed 233.51% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 2.56 in 2021, then crashed by 233.51% to 3.42 in 2022, then increased by 1.98% to 3.35 in 2023, then dropped by 10.32% to 3.7 in 2024, then plummeted by 33.12% to 4.92 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Equity Ratio are 4.92 (Q4 2025), 4.28 (Q3 2025), and 4.4 (Q2 2025).